Alexion Pharmaceuticals Inc. (ALXN) stock moves up, “Neutral” rating reaffirmed by Wedbush Analysts

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) shares rose on Monday Dec 5 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, the Dow Industrials on Monday opened at an all-time high as investors dismissed concerns about the outcome of Italy’s referendum on Sunday.

The Dow Jones Industrial Average rose DJIA, +0.41% 85 points, or 0.5%, at 19,260, the S&P 500 index SPX, +0.42% began trade 9 points, or 0.4%, higher at 2,201, while the Nasdaq Composite Index COMP, +0.43% advanced 27 points, or 0.5%, at 5,282.

Wedbush analysts reiterated its Neutral rating on Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) in a note to investors, making it one of the more closely watched stocks on Wall Street. The company currently has a rating of Neutral on the shares. The one-year price target of $171.67 is higher than the opening price of $124.09, resulting a number of other analysts to report on the stock in recent days. Looking back over the last 52 weeks, Alexion Pharmaceuticals Inc. stock has a high of $193.45. Stock prices often move to the upside on recommendations and new price targets of professional analysts.

Shares of Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) opened at $124.09 on Tuesday and has traded in a range between, $123.85 and $127.35, and last traded at $126.69, a jump of $3.73 or 3.03% compared to the previous closing price.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) currently has a market cap of 28.40B.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) Average Daily Trading Volume

The stock’s average daily volume is 2,100,670 shares out of a total float 223,139,000 and some 242,585 shares traded hands yesterday, below normal. Swing traders often use upticks in trading volume to determine heavy volume growth or dissemination by institutional investors, so trading volume is likely to increase in the next few days.

As with all possible breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to indicate that fund managers and other professional investors are jumping in.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have teams of analysts researching thousands of stocks. So watching their interests is a good way to ensure you are buying the right stocks.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of successful trades.

With that in mind, Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) now has a 50-day MA of $122.56 and 200-day MA of $128.72. It has traded in a 52-week range between $110.56 – 193.45 and today’s last price is 34.51%% lower than the 52 week high of $193.45.

Earnings growth is an important factor to look at when buying stocks and investors identify companies that have been successful at growing their earnings at least 25% or more over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *